4//SEC Filing
JEFFS ROGER 4
Accession 0001231615-25-000008
CIK 0001579428other
Filed
Sep 1, 8:00 PM ET
Accepted
Sep 2, 7:11 PM ET
Size
4.8 KB
Accession
0001231615-25-000008
Insider Transaction Report
Form 4
JEFFS ROGER
Director
Transactions
- Sale
Common Stock
2025-09-02$123.68/sh−13,464$1,665,228→ 57,510 total
Footnotes (3)
- [F1]Represents the sale of underlying shares of previously exercised stock options.
- [F2]Such transaction was pursuant to a pre-approved 10b5-1 plan which has now been completed.
- [F3]Represents the weighted average sale price of a series of open market transactions with sale prices ranging between $121.30 and $124.60.
Documents
Issuer
Axsome Therapeutics, Inc.
CIK 0001579428
Entity typeother
Related Parties
1- filerCIK 0001231615
Filing Metadata
- Form type
- 4
- Filed
- Sep 1, 8:00 PM ET
- Accepted
- Sep 2, 7:11 PM ET
- Size
- 4.8 KB